229 related articles for article (PubMed ID: 31215026)
1. Soluble epoxide hydrolase inhibitor, TUPS, attenuates isoproterenol/angiotensin II-induced cardiac hypertrophy through mammalian target of rapamycin-mediated autophagy inhibition.
Zhang H; Zhang K; Liang J; Yan W; Wu F; Xu W; Wu Z; Chen Y; Pan R; Wu G
J Pharm Pharmacol; 2019 Aug; 71(8):1291-1300. PubMed ID: 31215026
[TBL] [Abstract][Full Text] [Related]
2. Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy.
Althurwi HN; Tse MM; Abdelhamid G; Zordoky BN; Hammock BD; El-Kadi AO
Br J Pharmacol; 2013 Apr; 168(8):1794-807. PubMed ID: 23176298
[TBL] [Abstract][Full Text] [Related]
3. Curcumin alleviates isoproterenol-induced cardiac hypertrophy and fibrosis through inhibition of autophagy and activation of mTOR.
Liu R; Zhang HB; Yang J; Wang JR; Liu JX; Li CL
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7500-7508. PubMed ID: 30468499
[TBL] [Abstract][Full Text] [Related]
4. Hexarelin protects cardiac H9C2 cells from angiotensin II-induced hypertrophy
Agbo E; Li MX; Wang YQ; Saahene RO; Massaro J; Tian GZ
Pharmazie; 2019 Aug; 74(8):485-491. PubMed ID: 31526442
[TBL] [Abstract][Full Text] [Related]
5. Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways.
Ba L; Gao J; Chen Y; Qi H; Dong C; Pan H; Zhang Q; Shi P; Song C; Guan X; Cao Y; Sun H
Phytomedicine; 2019 May; 58():152765. PubMed ID: 31005720
[TBL] [Abstract][Full Text] [Related]
6. Suppression of calcium‑sensing receptor ameliorates cardiac hypertrophy through inhibition of autophagy.
Liu L; Wang C; Lin Y; Xi Y; Li H; Shi S; Li H; Zhang W; Zhao Y; Tian Y; Xu C; Wang L
Mol Med Rep; 2016 Jul; 14(1):111-20. PubMed ID: 27176663
[TBL] [Abstract][Full Text] [Related]
7. Deletion of soluble epoxide hydrolase attenuates cardiac hypertrophy via down-regulation of cardiac fibroblasts-derived fibroblast growth factor-2.
Zhang H; Wang T; Zhang K; Liu Y; Huang F; Zhu X; Liu Y; Wang MH; Tang W; Wang J; Huang H
Crit Care Med; 2014 May; 42(5):e345-54. PubMed ID: 24448199
[TBL] [Abstract][Full Text] [Related]
8. Aliskiren attenuates cardiac dysfunction by modulation of the mTOR and apoptosis pathways.
Zhao Z; Liu H; Guo D
Braz J Med Biol Res; 2020; 53(2):e8793. PubMed ID: 31994601
[TBL] [Abstract][Full Text] [Related]
9. Effects of Sirt3‑autophagy and resveratrol activation on myocardial hypertrophy and energy metabolism.
Wang HN; Li JL; Xu T; Yao HQ; Chen GH; Hu J
Mol Med Rep; 2020 Aug; 22(2):1342-1350. PubMed ID: 32468001
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 epoxygenase metabolite, 14,15-EET, protects against isoproterenol-induced cellular hypertrophy in H9c2 rat cell line.
Tse MM; Aboutabl ME; Althurwi HN; Elshenawy OH; Abdelhamid G; El-Kadi AO
Vascul Pharmacol; 2013; 58(5-6):363-73. PubMed ID: 23466634
[TBL] [Abstract][Full Text] [Related]
11. Plantago asiatica L. seeds extract protects against cardiomyocyte injury in isoproterenol- induced cardiac hypertrophy by inhibiting excessive autophagy and apoptosis in mice.
Fan W; Zhang B; Wu C; Wu H; Wu J; Wu S; Zhang J; Yang X; Yang L; Hu Z; Wu X
Phytomedicine; 2021 Oct; 91():153681. PubMed ID: 34371252
[TBL] [Abstract][Full Text] [Related]
12. NLRC5 enhances autophagy via inactivation of AKT/mTOR pathway and ameliorates cardiac hypertrophy.
Ba B; Mayila A; Guo Y; Xu J; Xing S; Cao G
Int J Exp Pathol; 2022 Feb; 103(1):23-30. PubMed ID: 34802165
[TBL] [Abstract][Full Text] [Related]
13. Icariin inhibits isoproterenol-induced cardiomyocyte hypertropic injury through activating autophagy via the AMPK/mTOR signaling pathway.
Hu L; Wang Z; Li H; Wei J; Tang F; Wang Q; Wang J; Zhang X; Zhang Q
Biochem Biophys Res Commun; 2022 Feb; 593():65-72. PubMed ID: 35063771
[TBL] [Abstract][Full Text] [Related]
14. Corosolic acid ameliorates cardiac hypertrophy via regulating autophagy.
Wang ZP; Shen D; Che Y; Jin YG; Wang SS; Wu QQ; Zhou H; Meng YY; Yuan Y
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31746323
[TBL] [Abstract][Full Text] [Related]
15. MiR-181a mediates Ang II-induced myocardial hypertrophy by mediating autophagy.
Li AL; Lv JB; Gao L
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5462-5470. PubMed ID: 29243791
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of soluble epoxide hydrolase confers cardioprotection and prevents cardiac cytochrome P450 induction by benzo(a)pyrene.
Aboutabl ME; Zordoky BN; Hammock BD; El-Kadi AO
J Cardiovasc Pharmacol; 2011 Mar; 57(3):273-81. PubMed ID: 21383588
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1-Autophagy Pathway Mediated Cardiomyocyte Hypertrophy Induced by Apelin-13.
Wu D; Xie F; Xiao L; Feng F; Huang S; He L; Liu M; Zhou Q; Li L; Chen L
DNA Cell Biol; 2017 Aug; 36(8):611-618. PubMed ID: 28537760
[TBL] [Abstract][Full Text] [Related]
18. The Inhibitory Effect of WenxinKeli on H9C2 Cardiomyocytes Hypertrophy Induced by Angiotensin II through Regulating Autophagy Activity.
Li J; Li Y; Zhang Y; Hu D; Gao Y; Shang H; Xing Y
Oxid Med Cell Longev; 2017; 2017():7042872. PubMed ID: 28713489
[TBL] [Abstract][Full Text] [Related]
19. Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3β signaling pathway.
Shang L; Pin L; Zhu S; Zhong X; Zhang Y; Shun M; Liu Y; Hou M
Chem Biol Interact; 2019 Jul; 307():21-28. PubMed ID: 31009642
[TBL] [Abstract][Full Text] [Related]
20. Myocardial hypertrophy is improved with berberine treatment via long non-coding RNA MIAT-mediated autophagy.
Zeng Z; Pan Y; Wu W; Li L; Wu Z; Zhang Y; Deng B; Wei S; Zhang W; Lin F; Song Y
J Pharm Pharmacol; 2019 Dec; 71(12):1822-1831. PubMed ID: 31612504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]